Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor related protein complex 2 subunit sigma 1 (AP2S1) encodes the small sigma subunit of the AP-2 adaptor complex, a heterotetramer involved in clathrin-mediated endocytosis at the plasma membrane[1][4][6]. AP-2 is responsible for cargo selection and assembly of clathrin-coated vesicles, recognizing specific endocytic motifs in transmembrane cargo molecules[1][2][4][8]. AP2S1 is directly implicated in receptor-mediated endocytosis and the recycling of synaptic vesicle membranes, and may play a role in extracellular calcium homeostasis[2][8]. Mutations in AP2S1, particularly at residue Arg15, cause familial hypocalciuric hypercalcemia type 3, a genetic disorder disrupting calcium homeostasis due to impaired calcium-sensing receptor trafficking[2][8]. No drugs are currently known to directly target AP2S1; its fundamental cellular role suggests therapeutic targeting would present challenges related to disruption of essential trafficking mechanisms[2][4][8].
Not established for any current therapeutics; theoretical mechanisms may involve modulation of endocytosis or calcium-sensing receptor trafficking[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor related protein complex 2 subunit sigma 1 (AP2S1).